Literature DB >> 32276020

Surgical management of pediatric renin-mediated hypertension secondary to renal artery occlusive disease and abdominal aortic coarctation.

Dawn M Coleman1, Jonathan L Eliason2, Robert Beaulieu2, Tatum Jackson2, Monita Karmakar3, David B Kershaw4, Zubin J Modi5, Santhi K Ganesh6, Minhaj S Khaja7, David Williams7, James C Stanley2.   

Abstract

BACKGROUND: Renovascular hypertension (RVH) associated with renal artery and abdominal aortic narrowings is the third most common cause of pediatric hypertension. Untreated children may experience major cardiopulmonary complications, stroke, renal failure, and death. The impetus of this study was to describe the increasingly complex surgical practice for such patients with an emphasis on anatomic phenotype and contemporary outcomes after surgical management as a means of identifying those factors responsible for persistent or recurrent hypertension necessitating reoperation.
METHODS: A retrospective analysis was performed of consecutive pediatric patients with RVH undergoing open surgical procedures at the University of Michigan from 1991 to 2017. Anatomic phenotype and patient risk factors were analyzed to predict outcomes of blood pressure control and the need for secondary operations using ordered and binomial logistic multinomial regression models, respectively.
RESULTS: There were 169 children (76 girls, 93 boys) who underwent primary index operations at a median age of 8.3 years; 31 children (18%) had neurofibromatosis type 1, 76 (45%) had abdominal aortic coarctations, and 28 (17%) had a single functioning kidney. Before treatment at the University of Michigan, 51 children experienced failed previous open operations (15) or endovascular interventions (36) for RVH at other institutions. Primary surgical interventions (342) included main renal artery (136) and segmental renal artery (10) aortic reimplantation, renal artery bypass (55), segmental renal artery embolization (10), renal artery patch angioplasty (8), resection with reanastomosis (4), and partial or total nephrectomy (25). Non-renal artery procedures included patch aortoplasty (32), aortoaortic bypass (32), and splanchnic arterial revascularization (30). Nine patients required reoperation in the early postoperative period. During a mean follow-up of 49 months, secondary interventions were required in 35 children (21%), including both open surgical (37) and endovascular (14) interventions. Remedial intervention to preserve primary renal artery patency or a nephrectomy if such was impossible was required in 22 children (13%). The remaining secondary procedures were performed to treat previously untreated disease that became clinically evident during follow-up. Age at operation and abdominal aortic coarctation were independent predictors for reoperation. The overall experience revealed hypertension to be cured in 74 children (44%), improved in 78 (46%), and unchanged in 17 (10%). Children undergoing remedial operations were less likely (33%) to be cured of hypertension. There was no perioperative death or renal insufficiency requiring dialysis after either primary or secondary interventions.
CONCLUSIONS: Contemporary surgical treatment of pediatric RVH provides a sustainable overall benefit to 90% of children. Interventions in the very young (<3 years) and concurrent abdominal aortic coarctation increase the likelihood of reoperation. Patients undergoing remedial surgery after earlier operative failures are less likely to be cured of hypertension. Judicious postoperative surveillance is imperative in children surgically treated for RVH.
Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic coarctation; Renal artery stenosis; Renovascular hypertension; pediatric

Mesh:

Substances:

Year:  2020        PMID: 32276020      PMCID: PMC7541589          DOI: 10.1016/j.jvs.2020.02.045

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  25 in total

1.  Angioplasty for pediatric renovascular hypertension: a 13-year experience.

Authors:  Guangchang Zhu; Fuliang He; Yongquan Gu; Hengxi Yu; Bing Chen; Zhiwei Hu; Weitao Liang; Zhonggao Wang
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

2.  Remedial operations for failed endovascular therapy of 32 renal artery stenoses in 24 children.

Authors:  Jonathan L Eliason; Dawn M Coleman; Enrique Criado; David B Kershaw; Neal B Blatt; David M Williams; Narasimham L Dasika; Kyung J Cho; James C Stanley
Journal:  Pediatr Nephrol       Date:  2015-12-01       Impact factor: 3.714

3.  Long-term outcome with surgical treatment of renovascular hypertension.

Authors:  J A O'Neill
Journal:  J Pediatr Surg       Date:  1998-01       Impact factor: 2.545

4.  Percutaneous transluminal angioplasty for renovascular hypertension in children: initial and long-term results.

Authors:  S Tyagi; U A Kaul; D K Satsangi; R Arora
Journal:  Pediatrics       Date:  1997-01       Impact factor: 7.124

Review 5.  The management of pediatric renovascular hypertension: a single center experience and review of the literature.

Authors:  Inna N Lobeck; Amir M Alhajjat; Phylicia Dupree; John M Racadio; Mark M Mitsnefes; Rebekah Karns; Greg M Tiao; Jaimie D Nathan
Journal:  J Pediatr Surg       Date:  2017-12-24       Impact factor: 2.545

6.  Results of surgical treatment for renovascular hypertension in children: 30 year single centre experience.

Authors:  Marike B Stadermann; Giovanni Montini; George Hamilton; Derek J Roebuck; Clare A McLaren; Michael J Dillon; Stephen D Marks; Kjell Tullus
Journal:  Nephrol Dial Transplant       Date:  2009-10-21       Impact factor: 5.992

7.  Pediatric renovascular hypertension: a thirty-year experience of operative treatment.

Authors:  J C Stanley; G B Zelenock; L M Messina; T W Wakefield
Journal:  J Vasc Surg       Date:  1995-02       Impact factor: 4.268

8.  Renovascular hypertension resulting from nonspecific aortoarteritis in children: midterm results of percutaneous transluminal renal angioplasty and predictors of restenosis.

Authors:  S Sharma; D Thatai; A Saxena; S S Kothari; S Guleria; M Rajani
Journal:  AJR Am J Roentgenol       Date:  1996-01       Impact factor: 3.959

9.  Pediatric renal artery occlusive disease and renovascular hypertension. Etiology, diagnosis, and operative treatment.

Authors:  J C Stanley; W J Fry
Journal:  Arch Surg       Date:  1981-05

10.  Tissue expander-stimulated lengthening of arteries for the treatment of midaortic syndrome in children.

Authors:  Heung Bae Kim; Khashayar Vakili; Gabriel J Ramos-Gonzalez; Deborah R Stein; Michael A Ferguson; Diego Porras; James E Lock; Gulraiz Chaudry; Ahmad Alomari; Steven J Fishman
Journal:  J Vasc Surg       Date:  2018-01-17       Impact factor: 4.268

View more
  5 in total

Review 1.  Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).

Authors:  Ramya Sivasubramanian; Kevin E Meyers
Journal:  Curr Hypertens Rep       Date:  2021-03-29       Impact factor: 5.369

2.  Vein Graft Aneurysm after Aorto-Renal Bypass for Childhood Renovascular Hypertension Due to Fibromuscular Dysplasia.

Authors:  Ara Cho; Hyunmin Ko; Seung-Kee Min
Journal:  Vasc Specialist Int       Date:  2022-06-30

Review 3.  Renovascular hypertension in pediatric patients: update on diagnosis and management.

Authors:  Juliana Lacerda de Oliveira Campos; Letícia Bitencourt; Ana Luisa Pedrosa; Diego Ferreira Silva; Filipe Ji Jen Lin; Lucas Teixeira de Oliveira Dias; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2021-04-13       Impact factor: 3.714

4.  Molecular genetic evaluation of pediatric renovascular hypertension due to renal artery stenosis and abdominal aortic coarctation in neurofibromatosis type 1.

Authors:  Dawn M Coleman; Yu Wang; Min-Lee Yang; Kristina L Hunker; Isabelle Birt; Ingrid L Bergin; Jun Z Li; James C Stanley; Santhi K Ganesh
Journal:  Hum Mol Genet       Date:  2022-02-03       Impact factor: 5.121

5.  Presentation, treatment, and outcome of renovascular hypertension below 2 years of age.

Authors:  Eda Didem Kurt-Sukur; Eileen Brennan; Meryl Davis; Colin Forman; George Hamilton; Nicos Kessaris; Stephen D Marks; Clare A McLaren; Kishore Minhas; Premal A Patel; Derek J Roebuck; Jelena Stojanovic; Sam Stuart; Kjell Tullus
Journal:  Eur J Pediatr       Date:  2022-07-06       Impact factor: 3.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.